about
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentArtemisinin Resistance in Plasmodium falciparum MalariaEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe role of early detection and treatment in malaria eliminationMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studyPopulation pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.Linking international clinical research with stateless populations to justice in global healthExploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trialRefugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study.Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010.Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border.A small amount of fat does not affect piperaquine exposure in patients with malaria.Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.Elimination of Plasmodium falciparum in an area of multi-drug resistance.A major genome region underlying artemisinin resistance in malariaThe epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and VietnamCommunity engagement on the Thai-Burmese border: rationale, experience and lessons learntEffect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.Numerical Distributions of Parasite Densities During Asymptomatic Malaria.Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapseAncillary Care: From Theory to Practice in International Clinical Research.Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.Exploitation and community engagement: can community advisory boards successfully assume a role minimising exploitation in international research?An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.Closing the translation gap for justice requirements in international research.Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar.Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern MyanmarComparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria“Nine Dimensions”: A multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria elimination in Karen/Kayin State, MyanmarAntenatal Ultrasound QuestionnaireThe practicality and sustainability of a community advisory board at a large medical research unit on the Thai-Myanmar border
P50
Q21090072-29443F69-1437-4365-8577-AB92D22878E5Q22061852-CBA404D9-80AD-4102-ADD9-DC61B71ED5CCQ24598695-9B773C94-30AB-482F-8B2B-0C5FE2F492CFQ26740068-8C6438EF-322F-4F29-8C6A-861D8A1953BFQ28487636-8FE233EB-5D6C-4B42-A832-B590F48D1F7EQ33622892-A7D72220-9DF5-42D1-A529-31A5FE8096D0Q33858099-8BDBB13B-4530-466D-B1AE-41AB48B2FE68Q33962805-FABDE6C9-3306-4D22-A60C-56EB808A9F50Q34049080-BB25907A-F08B-48BA-AA12-731007BD7A55Q34238456-5BD8B30C-81B6-48B4-B4FA-40699FC606F4Q34344807-DF0633B6-4C5C-4892-B3C5-C68DEAF79F86Q35095937-6C01F76B-88AE-4DBD-96F3-A49F3A2CC742Q35191426-B61A77A2-0613-4C27-BFAC-EB3D0A0AA6D8Q35217991-31419733-6551-4E52-BBFA-D00BF0F5CAECQ35806356-8B2375FC-82E9-4D60-AE57-94F660464C8EQ35957194-8FF05E6F-CA6A-4CA8-8FCC-7B16163F8B60Q35969854-B5ABC122-7C34-4D31-A5F0-55F6EC997EEAQ36111884-F4DF8AF9-8F8C-41ED-B44C-0FC2755BE93EQ36234232-C31703F4-6780-40C1-A925-07B6E60DA99EQ36584916-E942BF8C-C5B3-4721-8631-873A1A2FF842Q36705880-DE4AD308-F236-4917-B583-B0C3F4A05F6DQ36898219-4C8CAF61-A252-4393-8A90-C96A32FD3B18Q37016093-8D6471BE-54CA-484F-BC1A-DE906A95AEBFQ37200509-4CFA2C85-CF04-41EA-B135-9D2E1DB58DEBQ38905356-70343D41-131D-44DF-A7CC-50C8DF6C6224Q43204540-49AB0741-7977-4F65-B8BA-EC9240E68021Q43536105-9FA934D7-AC65-4153-9EAA-82E13007282FQ43601958-90D2F2BA-4274-4D33-A3B1-091C73642CFEQ44076080-03C1CC3E-82E0-48BB-A3AA-0B4AA50511ADQ48023924-36A82A2C-006F-4C07-8D4F-A1D8714E1414Q55024751-5309E101-A653-431C-8580-10692AB4A94DQ56356601-ACCC70FE-9CED-4D54-8A8B-DC6DD22E43A3Q56363393-CD2A9EF8-D8D8-405F-A7DF-918E02251951Q57032930-9DD2D1D8-41D6-4501-914A-9FD408021DFBQ57056680-023156F1-92DF-4A03-9408-DF17A0CF6CE6Q59271250-CFFAC592-BA1B-43B4-BDEB-DAE1F823B846
P50
name
Khin Maung Lwin
@en
Khin Maung Lwin
@nl
type
label
Khin Maung Lwin
@en
Khin Maung Lwin
@nl
prefLabel
Khin Maung Lwin
@en
Khin Maung Lwin
@nl